Novak D - Search Results

1

Hüser L, Novak D, Umansky V, Altevogt P, Utikal J. Hüser L, et al. Among authors: novak d. Expert Opin Ther Targets. 2018 Dec;22(12):983-991. doi: 10.1080/14728222.2018.1538359. Epub 2018 Oct 26. Expert Opin Ther Targets. 2018. PMID: 30366514 Review.

2

TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells.

Weina K, Wu H, Knappe N, Orouji E, Novak D, Bernhardt M, Hüser L, Larribère L, Umansky V, Gebhardt C, Utikal J. Weina K, et al. Among authors: novak d. Pigment Cell Melanoma Res. 2016 Jul;29(4):453-8. doi: 10.1111/pcmr.12483. Pigment Cell Melanoma Res. 2016. PMID: 27105574

3

SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.

Hüser L, Sachindra S, Granados K, Federico A, Larribère L, Novak D, Umansky V, Altevogt P, Utikal J. Hüser L, et al. Among authors: novak d. Int J Cancer. 2018 Dec 15;143(12):3131-3142. doi: 10.1002/ijc.31609. Epub 2018 Oct 16. Int J Cancer. 2018. PMID: 29905375 Free article.

4

SOX2 in development and cancer biology.

Novak D, Hüser L, Elton JJ, Umansky V, Altevogt P, Utikal J. Novak D, et al. Semin Cancer Biol. 2020 Dec;67(Pt 1):74-82. doi: 10.1016/j.semcancer.2019.08.007. Epub 2019 Aug 11. Semin Cancer Biol. 2020. PMID: 31412296 Free article. Review.

5

FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor.

Sun Q, Novak D, Hüser L, Poelchen J, Wu H, Granados K, Federico A, Liu K, Steinfass T, Vierthaler M, Umansky V, Utikal J. Sun Q, et al. Among authors: novak d. Int J Cancer. 2021 Aug 1;149(3):657-674. doi: 10.1002/ijc.33591. Epub 2021 May 6. Int J Cancer. 2021. PMID: 33837564 Free article.

6

Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives.

Bernhardt M, Galach M, Novak D, Utikal J. Bernhardt M, et al. Among authors: novak d. Biotechnol J. 2012 Jun;7(6):810-21. doi: 10.1002/biot.201100347. Epub 2012 May 16. Biotechnol J. 2012. PMID: 22589234 Review.

7

From skin to other cell types of the body.

Novak D, Weina K, Utikal J. Novak D, et al. J Dtsch Dermatol Ges. 2014 Sep;12(9):789-92. doi: 10.1111/ddg.12403. Epub 2014 Aug 1. J Dtsch Dermatol Ges. 2014. PMID: 25087921 Free article. Review.

8

Function and significance of MicroRNAs in benign and malignant human stem cells.

Utikal J, Abba M, Novak D, Moniuszko M, Allgayer H. Utikal J, et al. Among authors: novak d. Semin Cancer Biol. 2015 Dec;35:200-11. doi: 10.1016/j.semcancer.2015.07.001. Epub 2015 Jul 17. Semin Cancer Biol. 2015. PMID: 26192966 Review.

9

Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.

Knappe N, Novak D, Weina K, Bernhardt M, Reith M, Larribere L, Hölzel M, Tüting T, Gebhardt C, Umansky V, Utikal J. Knappe N, et al. Among authors: novak d. Stem Cells. 2016 Apr;34(4):832-46. doi: 10.1002/stem.2284. Epub 2016 Jan 19. Stem Cells. 2016. PMID: 26753613

10

SOX5 is involved in balanced MITF regulation in human melanoma cells.

Kordaß T, Weber CE, Oswald M, Ast V, Bernhardt M, Novak D, Utikal J, Eichmüller SB, König R. Kordaß T, et al. Among authors: novak d. BMC Med Genomics. 2016 Feb 29;9:10. doi: 10.1186/s12920-016-0170-0. BMC Med Genomics. 2016. PMID: 26927636 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

549 results

Search Page